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T
he Dundee experimental bald rat (DEBR) is one of 
two animal models for alopecia are at a (AA) that may 
prove invaluable for investigating the etiology, 
pathogenesis, and progression of the disease. The 
DEBR rat, bred at the University of Dun dee, exists as 
brown hooded and black hooded isogenic sublines with different 
haplotypes but with common disease expression. 
DEBR rats develop and maintain an apparently normal coat of 
hair until they reach 4-5 months of age. Subsequently, active, 
acute hair loss ensues until the lesion reaches a chronic stable 
phase at 10-12 months of age. The lesion may persist as a slight 
thinning of the pelage through to entire loss of hair with most 
follicles arrested in a dystrophic anagen state. As in human AA, 
hair loss correlates with a prominent peri- and intrabulbar 
monolymphocytic cell infiltrate associated with major histocom­
patibility complex class II and intercellular adhesion molecule-1 
expression [1]. Well before the onset of hair loss, such lympho­
cytic activity is foreshadowed by the development of an in­
creased perifollicular presence of major histocompatibility com­
plex class n+ cells, macrophages, and particularly CD8+ 
(cytotoxiclsuppressor) cells. In lesional follicles, where there is 
overt disruption of lower follicle epithelial elements, the in­
trafollicular infiltrate is composed of CD8+ cells and macro­
phages. DEBR rats respond with hair regrowth to immunosup­
pressive therapies such as corticosteroids and cyclosporin [2]. 
Immune activity associated with AA has led to speculation that 
autoantibodies to components of the hair follicle may be present in 
the sera of AA sufferers. Although extensive efforts have been made 
to implicate such autoantibodies in the pathogenesis of AA over the 
last 20 years, only recently have hair follicle autoantibodies been 
found* [3]. Our investigation used a modification of standard 
immunofluorescent techniques to examine individual sera from 
DEBR rats for the presence of autoantibodies to the hair follicle and 
other organs. 
DEBR rats and normal PVG/Ola rats provided sera and various 
tissues including vibrissa and pelage follicles, thyroid, parathyroid, 
kidney, adrenal gland, brain, liver, muscle, heart, stomach, and 
lung. Sera, partially purified by ammonium sulphate precipitation 
and diluted 1:80 in tris-phosphate-buffered saline, were applied to 
frozen tissue sections for 72 h at 4°C. After incubation for 1 h with 
fluorescein isothiocyanate-conjugated mouse anti-rat IgG diluted 
1:100, the sections were examined for distribution and intensity of 
specific staining. 
Subsets ofDEBR sera contained IgG autoantibodies that targeted 
various hair follicle epidermal differentia. Although there was 
heterogeneity, even between litter mates, in autoantibody specific­
ity the range of target tissues was defined as differentiating hair 
cortex and cuticle and the inner root sheath, especially Henle's 
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layer (Fig 1). Some sera also contained autoantibodies specific for 
skeletal muscle tissue andlor nuclear antigens. Of ten young 
pre-lesional rats with no hair loss, three had hair follicle autoanti­
bodies, seven had skeletal muscle autoantibodies, and three had 
antinuclear antibodies. Nine of ten active lesional rats with pro­
gressing hair loss had follicle autoantibodies, four had skeletal 
muscle autoantibodies and three had antinuclear antibodies. All ten 
Figure 1. Section through a normal PVG/O!a rat vibrissa bulb 
stained using DEBR serum. There is strong specific staining for the inner 
root sheath, Henle, Huxley, and cuticle layers (an'o,,') with light specific 
staining for the hair cortex (a/Towhead) (har, 50 /Lm). 
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established lesional rats had autoantibodies specific for components 
of the hair follicle of which one had skeletal muscle autoantibodies 
and four had antinuclear antibodies. For autoantibodies against the 
inner root sheath in some active lesional rats, sera could be titrated 
to 1:1280 and still maintain staining intensity. Control sera from 
PVG/Ola rats showed no positive staining for hair-follicle compo­
nents or other tissues. 
An earlier study by Michie, t which stimulated the current work, 
detected autoantibody activity in DEBR serum with staining of hair 
cuticle and fiber. Using sera from AA patients Calver et a/* reported 
staining for the outer root sheath, inner root sheath, hair shaft, 
epidermis, sebaceous glands, and apocrine glands, with individual 
sera exhibiting heterogeneity in autoantibody specificity. Our 
findings revealed a more restricted range of epithelial targets in the 
DEBR rat. The autoantibodies raised in the DEBR rat were against 
normally expressed antigens as they were able to target epithelia in 
normal PVG/Ola rat tissue as well as lesional DEBR follicles. Nor 
were the autoantibodies species specific as they targeted the same 
epithelia in human scalp sections. 
Autoantibodies against striated muscle were particularly promi­
nent in serum from prelesional rats. Cell antinuclear antibodies as 
found in 10 of the 30 DEBR rat sera when tested on a rat embryonic 
epidermal cell line were further characterized as staining for 
nucleoli, centrosomes, centromeres, and nuclear lamina or pre­
sented as a homogeneous nuclear stain. Autoantibodies against 
other tissues were not detected. When considering all types of 
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autoantibodies, nine of ten prelesional DEBR rats expressed some 
form of autoantibody at a serum dilution of 1:80. 
Our findings clearly show that in the DEBR model, as in human 
AA, the immune system can be presented with a range of poten­
tially stimulatory self antigens derived from hair-follicle epidermal 
differentia. Because the production of antibody seemed to coincide 
with the development of the cellular infiltrate and there was 
variable targeting of a range of follicle dilferentia, autoantibodies in 
DEBR serum may be a consequence of cellular disruption by 
immune cells and subsequent release of autoantigens. This presence 
of autoantibodies ahead of actual hair loss could indicate their 
production and possible active participation in the progression of 
the lesion. 
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Topical Immunotherapy in Children with 
Alopecia Areata 
Giovanni Orecchia and Piergiorgio Malagoli 
Department of Dermatology, University of Pavia, Pavia, Italy 
I
n the last decade in Europe, topical squaric acid dibutylester 
(SAD BE) has been used in the treatment of alopecia areata 
in the adult population. This study attempts to define this 
drug's effectiveness and handiness in pediatric patients suf­
fering from severe alopecia areata, who are psychologically 
disturbed and resistant to other therapies. 
Twenty-eight children (under 13 years old), suffering from 
extensive and long-standing alopecia areata and who were not 
responsive to conventional therapies, were sensitized on the head 
with 2% of SADBE in acetone and treated with weekly applica­
tions. The treatment lasted 12 months. In nine patients (32.1%) 
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complete or cosmetically acceptable regrowth was achieved and in 
another six (21.4%) a significant hair regrowth appeared. No 
correlation was found between response and sex, age of onset of the 
illness, extent, duration, and dilferent clinical types of the disease. 
Fourteen of 28 patients were followed up for a period ranging from 
18 months to 8 years: even if SADBE is not a cure for alopecia, it 
remained efficacious in relapses, too. 
In severe forms of AA, under psycologic disturbed personal and 
family situations [1], treatment with SADBE seems justified for 
children, too. Indeed, particularly in these patients, it has many 
advantages compared with other therapies that are either associated 
with serious side effects or, in the judgment of some authors, 
ineffective: it is a topical treatment, it is easy to apply (home therapy), 
and furthermore it is readily accepted because it is a clean therapy 
(unlike topical anthralin). In addition it is not time consuming (there is 
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